MedTrace Logo

Safety Study of AZT-04 for Cosmetic Use

NCT03820076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2020-07-09

No results posted yet for this study

Summary

Double Blind, Three Cohort, Placebo-controlled Trial to Assess Safety, Tolerance and Induced Bacterial Colony Counts of Three Ascending Doses of AZT-04 in Healthy Adult Volunteers

Conditions

  • Study of Three Doses of AZT-04 for Skin Appearance

Interventions

OTHER

AZT-04

Staphylococcus epidermidis

Sponsors & Collaborators

  • RCTs

    collaborator INDUSTRY

  • Azitra Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-17
Primary Completion
2019-01-21
Completion
2019-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03820076 on ClinicalTrials.gov